#NASDAQ $RGC : Second investigational study of RGC
Post# of 103030
(Total Views: 197)
Posted On: 06/13/2022 11:32:54 AM
#NASDAQ $RGC : Second investigational study of RGC-COV19™ replicates results of earlier trial in eliminating COVID-19 symptoms.
Founded in 2014, Hong Kong-based Regencell Bioscience (NASDAQ:RGC) is an early clinical stage bioscience company using Traditional Chinese Medicine (TCM) approach to develop standardized TCM formulas to holistically treat autism spectrum disorder (ASD) and attention deficit hyperactivity disorder (ADHD) in children, and infectious diseases such as the coronavirus disease (COVID-19).
https://finance.yahoo.com/news/rgc-second-inv...00752.html
Founded in 2014, Hong Kong-based Regencell Bioscience (NASDAQ:RGC) is an early clinical stage bioscience company using Traditional Chinese Medicine (TCM) approach to develop standardized TCM formulas to holistically treat autism spectrum disorder (ASD) and attention deficit hyperactivity disorder (ADHD) in children, and infectious diseases such as the coronavirus disease (COVID-19).
https://finance.yahoo.com/news/rgc-second-inv...00752.html
(0)
(0)Scroll down for more posts ▼